Lobbying client
NANODX
Manufacturing Medical Devices, point-of-care diagnostic solutions
Filings
27
Filed by
1
Reported in-house
—
Reported by firms
$605,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2026
Filings
27 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Report 2nd Quarter 2021
|
ACUITY STRATEGIC PARTNERS LLC | $20,000 reported |
|
1st Quarter - Amendment 1st Quarter 2021
|
ACUITY STRATEGIC PARTNERS LLC | $20,000 reported |
|
1st Quarter - Reportreplaced 1st Quarter 2021
|
ACUITY STRATEGIC PARTNERS LLC | — reported |
|
4th Quarter - Report 4th Quarter 2020
|
ACUITY STRATEGIC PARTNERS LLC | $15,000 reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
ACUITY STRATEGIC PARTNERS LLC | $15,000 reported |
|
2nd Quarter - Report 2nd Quarter 2020
|
ACUITY STRATEGIC PARTNERS LLC | $15,000 reported |
|
Registration 2nd Quarter 2020
|
ACUITY STRATEGIC PARTNERS LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| ACUITY STRATEGIC PARTNERS LLC | 25 | $605,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medicare/Medicaid | MMM | 26 |
| Defense | DEF | 6 |
| Health Issues | HCR | 4 |
| Medical/Disease Research/Clinical Labs | MED | 4 |
| Budget/Appropriations | BUD | 4 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.